Deciphera Pharmaceuticals (DCPH) Tops Q1 EPS by 10c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q1 EPS of ($0.80), $0.10 better than the analyst estimate of ($0.90). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $26.43 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
• Melco Resorts & Entertainment (MLCO) Misses Q2 EPS by 7c